期刊文献+

代谢综合征患者葡萄糖代谢率与血浆抵抗素关系的研究 被引量:2

Relationship of Glucose Metabolic Rate and Plasma Resistin Levels in Subjects with Metabolic Syndrome
下载PDF
导出
摘要 目的探讨代谢综合征(MS)人群葡萄糖代谢率(M)与血浆抵抗素(resistin)水平变化的关系。方法筛选30例MS病例和20例健康对照组。所有受试者均进行高胰岛素-正常血糖钳夹试验;检测血浆resistin水平及空腹胰岛素、血糖、血脂等生化等生化指标;测定血压、腰围(WC)、身高、体重等人体参数。结果 (1)高胰岛素-正常血糖钳夹试验稳态时(120-150 min)对照组和MS组的M分别为8.33±1.59 mg.kg-1.min-1和4.13±1.34 mg.kg-1.min-1,MS组的M显著低于对照组,差异有统计学意义(P<0.01)。2.对照组与MS组的血浆resistin水平分别为11.35±4.04 ng/mL与10.91±4.02 ng/mL,与对照组比较,MS组的血浆resistin水平无显著性差异(P>0.05)。3.在MS组,resistin与体重指数(BMI)、WC、空腹血糖(FPG)、2小时血糖(2 hPG)、空腹胰岛素(FINS)、甘油三酯(TG)、高密度脂蛋白-胆固醇(HDL-C)、M等指标的相关系数r值分别为:0.156、0.115、0.138、-0.057、0.103、0.175、-0.149及-0.135,P均>0.05,resistin与上述指标无相关关系。结论 (1)本研究成功应用高胰岛素-正常血糖钳夹技术评估了30例MS患者和20例正常对照人群的M,结果显示本组MS患者的M显著低于对照组,提示本组MS患者胰岛素敏感性降低,存在明显的胰岛素抵抗IR。(2)本研究未观察到本组MS患者血浆resistin水平的明显变化,也未发现其胰岛素敏感性的变化与resistin有相关性,提示临床MS患者resistin与IR关系的复杂性及可能存在异质性,有待今后进一步研究。 Objective To investigate the changes of glucose metabolic rate and plasma resistin levels in subjects with metabolic syndrome(MS).Methods 30 subjects with MS were selected as MS group.20 normal adults were selected as control group.Glucose metabolic rate was evaluated by way of hyperinsulinemic euglycemia clamp technique and plasma resistin concentrations were detected by enzyme linked immunosorbent assay(ELISA).Blood pressure,waist circumference(WC),body weight and body height were measured.Results(1)During the steady state(last 30 mins) in the hyperinsulinemic euglycemia clamp,M in MS group was significantly lower than that in controls.(4.13±1.34 mg·kg-1·min-1 vs 8.33±1.59 mg·kg-1·min-1,respectively,P0.01).(2)Plasma resistin levels in MS group was no significantly difference from that in controls(10.91±4.02 vs 11.35±4.04 ng/mL,respectively,P0.05 for all correlations).(3)No significant association of resistin with BMI,WC,FPG,2 hPG,FINS,TG,HDL-C and M was found.(r=0.156,0.115,0.138,-0.057,0.103,0.175,-0.149,-0.135,respectively,P0.05 for all correlations).Conclusion (1)In this study,we successfully evaluated insulin sensitivity of 50 subjects(30 in MS group and 20 in controls) by means of hyperinsulinemic euglycemic clamp technique.Our finding showed insulin sensitivity of subjects with MS in this study was significantly decreased.(2)Plasma resistin levels were not significantly different between MS and control group,suggesting that plasma resistin levels were not be associated with IR in subjects with MS.
出处 《中国实验诊断学》 北大核心 2011年第2期277-280,共4页 Chinese Journal of Laboratory Diagnosis
基金 广东省科技计划项目(2007B080702015) 广东省医学科研基金(A2007632) 佛山市科技攻关项目(200708018)
关键词 代谢综合征 抵抗素 高胰岛素-正常血糖钳夹试验 葡萄糖代谢率 Metabolic syndrome Hyperinsulinemic euglycemia clamp Resistin Glucose metabolic rate
  • 相关文献

参考文献11

  • 1Potenza MV,Mechanick JI.The metabolic syndrome:definition,global impact,and pathophysiology[J].Nutr Clin Pract,2009,24(5):560.
  • 2Gnacińska M,Malgorzewicz S,Stojek M,et al.Role of adipokines in complications related to obesity:a review[J].Adv Med Sci,2009,54(2):150.
  • 3Karbowska A,Boratyńska M,Klinger M.Resistin:a pathogenic factor or a biomarker of metabolic disorders and inflammation[J] ? Postepy Hig Med Dosw,2009,63:485.
  • 4宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志(1006-6187),2005,13(3):178-180. 被引量:611
  • 5Defronzo RA,Tobin JD,Andres R.Glucose clamp technique:a method for quantifying insulin secretion and resistance[J].Am J Physilo,1979,237(3):E214.
  • 6贾伟平,陈蕾,项坤三,陆俊茜,包玉倩,薛凤仙,陆蔚.扩展高胰岛素-正葡萄糖钳夹技术的建立[J].中华内分泌代谢杂志,2001,17(5):268-271. 被引量:46
  • 7Tomimoto S,Ojika T,Shintani N,et al.Markedly reduced white adipose tissue and increased insulin sensitivity in adcyap1-deficient mice[J].J Pharmacol Sci,2008,107(1):41.
  • 8Domínguez S,Cabrera A,Almeida D,et al.Inverse association between serum resistin and insulin resistance in humans[J].Diabetes Res Clin Pract,2008,82(2):256.
  • 9Degawa-Yamauchi M,Bovenkerk JE,Juliar BE,et al.Serum resistin (FIZZ3) protein is increased in obese humans[J].J Clin Endocrinol Metab,2003,88(11):5452.
  • 10Senay A,Mithat B,Alpaslan T,et al.Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome[J].Gynecol Endocrinol,2009,15:1.

二级参考文献23

  • 1Lee K U,Diabetologia,1988年,31卷,285页
  • 2Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med,2003,4(suppl 6):s11-s18.
  • 3Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol,1994,73:460-468.
  • 4Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med,2003,115(suppl 8A):24s-28s.
  • 5Robins SJ, Rubins HB, Faas FH, et al. Insulin resistance and cardiovascular events with low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care,2003,26:1513-1517.
  • 6Steinmetz A, Fenselau S, Schrezenmeir J. Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diabetes,2001,109:s548-559.
  • 7Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA, 2001,285:1585-1591.
  • 8Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004,27:1182-1186.
  • 9Lindstrom J, Louheranta A, Mannelin M. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care, 2003,26:3230-3236.
  • 10Tuomilehto J, Lindstrm J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM, 2001,344:1343-1350.

共引文献653

同被引文献18

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部